The P&G-Merck KGaA Consumer Health Business Merger

Global Economic Impact of Coronavirus – Assessment and Mitigation (B)
Case Code: BSTR618
Case Length: 14 Pages
Period: -
Pub Date: 2020
Teaching Note: Available
Price: Rs.400
Organization: Procter & Gamble Company
Industry: -
Countries: United States
Themes: M&A, Divestment
Global Economic Impact of Coronavirus – Assessment and Mitigation (B)
Abstract Case Intro 1 Case Intro 2 Excerpts


On April 18, 2018, US multinational FMCG major Procter & Gamble Company (P&G) acquired a 100% stake in the Consumer Health Business (CHB) of Merck KGaA (Merck), a global pharmaceutical company headquartered in Germany. David Taylor, Chairman of the Board, President and Chief Executive Officer of P&G, said, “We like the steady, broad-based growth of the OTC Health Care market and are pleased to add the Consumer Health portfolio and people of Merck KGaA, Darmstadt, Germany, to the P&G family.” Stefan Oschmann, Chairman of the Executive Board and CEO of Merck, said, “Consumer Health is a strong business that deserves the best possible opportunities for its future development. With P&G we have found a strong, highly recognized player who has the necessary scale to successfully drive the business going forward.”..

Buy this case study (Please select any one of the payment options)

Price: Rs.400
Price: Rs.400
PayPal (9 USD)

Custom Search